Track the Delivra Health Brands Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the oversight of SEDI. Market capitalisation: €3.1m. The latest transaction was filed on 15 June 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Davey, Gord. The full history is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Delivra Health Brands Inc. Strong Buy (bullish), based on 1 analysts. Average price target: CA$0.53.
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,617 of 28,717 companies
74.7
score / 100
Value
96
Quality
53
FCF yld20%
Earn yld23%
EV/EBITDA2.5x
ROE-28%
Gross mgn52%
Net mgn7.1%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
500 shares@ CA$0.120.6% of flowCommon SharesTSXSEDI:4735844
Canonical exit: 10 Sept 2026 (T+90)
9 of 9 declarations
About Delivra Health Brands Inc.
Delivra Health Brands Inc. is a Canadian company focused on the development and marketing of natural health products. It is listed on the Toronto Stock Exchange under the symbol XTSE.